Status:
UNKNOWN
Knowledge of Pregnant Women Concerning Pertussis, Vaccination Against Pertussis and Cocooning Strategy
Lead Sponsor:
Université de Reims Champagne-Ardenne
Conditions:
Pertussis
Eligibility:
FEMALE
18+ years
Brief Summary
In France, it has been recommended since 2022 that pregnant women be vaccinated against pertussis from 20 to 36 weeks' gestation. This vaccination schedule is inspired by the Anglo-Saxon model and st...
Detailed Description
The aim is to describe pregnant women's knowledge concerning pertussis, vaccination against pertussis during pregnancy and the cocooning strategy.
Eligibility Criteria
Inclusion
- Pregnant between 20 and 41 weeks of amenorrhea
- Primiparous
- aged more than 18
- Agreed to participate in the study
Exclusion
- Multiparous
- Protected by law (guardianship, guardianship, safeguarding of justice)
- Not agreed to participate in this study
Key Trial Info
Start Date :
December 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2024
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06114160
Start Date
December 1 2023
End Date
May 1 2024
Last Update
November 7 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.